You are here » Home » Companies » Company Overview » Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals & Pharmaceuticals Ltd.

BSE: 524396 Sector: Health care
NSE: BIOFILCHEM ISIN Code: INE829A01014
BSE LIVE 14:51 | 21 Aug 17.50 -0.45
(-2.51%)
OPEN

18.00

HIGH

18.65

LOW

17.10

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 18.00
PREVIOUS CLOSE 17.95
VOLUME 3179
52-Week high 25.70
52-Week low 6.27
P/E 15.22
Mkt Cap.(Rs cr) 28
Buy Price 17.10
Buy Qty 5.00
Sell Price 17.50
Sell Qty 995.00
OPEN 18.00
CLOSE 17.95
VOLUME 3179
52-Week high 25.70
52-Week low 6.27
P/E 15.22
Mkt Cap.(Rs cr) 28
Buy Price 17.10
Buy Qty 5.00
Sell Price 17.50
Sell Qty 995.00

Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM) - Director Report

Company director report

To

The Members of

Biofil Chemicals and Pharmaceuticals Limited

Your Directors are pleased to present the 31st Annual Report on the business andoperation of the Company together with the Audited Financial Statements for the year endedMarch 31 2016.

1. STATE OF AFFAIRS FINANCIAL PERFORMANCE AND FUTURE OUTLOOK:

1.1 FINANCIAL HIGHLIGHTS AND SUMMARY

The performance highlights and summarized financial results of the Company are givenbelow:

(Rupees in Lakhs except EPS)

PARTICULARS Year ended Year ended
31st March 2016 31st March 2015
Total Income 1369.84 632.34
Total Expenditure 1271.77 558.80
Profit/(Loss) before Exceptional & Extraordinary Items & Tax 98.07 73.54
Exceptional Items 0.00 0.00
Extraordinary Items 0.00 0.00
Profit/(Loss) before tax 98.07 73.54
Provision for Tax
- Current Tax 18.69 14.01
- Deferred Tax 0.00 0.00
- Earlier year Tax 1.12 0.81
Profit/Loss after tax 78.26 58.72
Surplus Carried to Balance Sheet 78.26 58.72
Paid up Equity Share Capital 1627.38 1627.38
Earning per share (Rs.10/- each) Basic & Diluted (in Rs.) 0.48 0.36

Pharma Industry also faces major economic and operational challenges there are stillsome economic issues related to this sector which has not been addressed yet by thegovernment such as export incentives cluster development incentives for API Industry andstreamlining regulation. Major operational issues for Pharma industries are nonavailability of major raw material or availability of raw material at increased pricesincreased legal risk. However board of the director are putting their full efforts to growthe business activities.

During the financial year your company has achieved the turnover of Rs. 1369.84 Lacs incomparison to previous year's turnover of Rs.632.34 Lacs and net profit of the company isRs.78.26 lacs in comparison to previous net profit of Rs.58.72 lacs.

Further your company shall continue to grow its business with leading pharmaceuticalCentral Public Sector Enterprises Bengal Chemicals and Pharmaceuticals Limited forproviding C&F facility and HLL Lifecare Limited for providing job work facility.

1.2 CHANGE IN NATURE OF BUSINESS

Company is dealing in Pharmaceuticals and Chemicals and it has also diversified itsbusiness activity and is dealing in Plastic and allied Products. During the year there wasno change in business activity of the company.

1.3 SHARE CAPITAL

The Paid-Up Equity Share Capital as at 31st March 2016 stood at Rs.16273800/-.During the year under review the company has not issued shares with differential votingrights nor has granted any stock option or sweat equity shares. As on 31st March 2016none of the Directors of the company hold instruments convertible into equity shares ofthe Company.

2. EXTRACT OF ANNUAL RETURN

The details forming part of the extract of the Annual Return in form MGT-9 as requiredunder Section 92 of the Companies Act 2013 is annexed as Annexure - A and forms anintegral part of this Report

3. NUMBER OF MEETINGS OF THE BOARD ITS COMMITTEES AND AGM

The details of the number of meetings of the Board and its committee held during theFinancial Year 2015-16 forms part of the Corporate Governance Report. Further Annualgeneral meeting of the Company for financial year 2014-2015 was held on 24th September2015.

4. DIVIDEND

Due to inadequate profit & accumulated losses in earlier years your Directors havenot recommended any dividend for the year under review.

5. AMOUNTS TRANSFERRED TO RESERVES

Due to accumulated losses company has not transferred any amount in reserve account.

6. DEPOSITS

The Company has not accepted any deposits within the meaning of Section 73 of theCompanies Act 2013 read with the Companies (Acceptance of Deposits) Rules 2014.

DISCLOSURE OF UNSECURED LOAN RECEIVED FROM DIRECTORS.

Pursuant to Section 2(31) Read with Rule 2(1)(viii) of Companies (Acceptance ofDeposits) Rules 2014 (including any statutory modification or re-enactment thereof forthe time being in force) the Company has not received any unsecured loan from directorduring the financial year.

7. DETAILS OF SUBSIDIARY JOINT VENTURE OR ASSOCIATES:

During the financial year ended on 31.03.2016 the Company did not have any subsidiaryjoint venture or associate company.

8. DETAILS OF DIRECTORS AND KEY MANAGERIAL PERSONNEL

Members at their 30th annual general meeting held on 24th September 2015 approved theappointment of Shri Subhash Chandra Swarnkar as an independent Director of the Companypursuant to Section 149 of the Companies Act 2013 who was appointed by Board of Directorsin their meeting held on 13th August 2015 as an additional director up to the 30th AGM.Further Shri Ramesh Chimanlal Shah resigned from the post of directorship of the companyw.e.f 15th November 2015 due to his pre-occupation and other personal reasons. YourBoard places on record his deep appreciation for valuable contribution made by him duringthe tenure as the director of the company.

Further Ms. Neha Shukla resigned from the post of the Company Secretary andCompliance officer (KMP) with effect from 13th February 2016 and Ms. Shikha Khilwani wasappointed as Company Secretary and Compliance officer (KMP) of the Company w.e.f. 13thFebruary 2016.

In accordance with the provisions of Section 152 of the Companies Act 2013 and theCompany's Articles of Association Mr. Romil Shah Director retires by rotation at theforthcoming Annual General Meeting and being eligible offers himself for re-appointment.The Board recommends his re-appointment for the consideration of the Members of theCompany at the ensuing Annual General Meeting.

The following have been designated as the Key Managerial Personnel of the Companypursuant to sections 2(51) and 203 of the Companies Act 2013 read with the Companies(Appointment and Remuneration of Managerial Personnel) Rules 2014:

1. Ramesh Shah Managing Director

2. Shikha Khilwani Company Secretary and Compliance officer (w.e.f. 13.02.2016)

3. Jitendra Kumar Sahu Chief Financial officer DISQUALIFICATIONS OF DIRECTORS

During the year declarations were received from the Directors of the Company pursuantto Section 164 of the Companies Act 2013. Board appraised the same and found that none ofthe director is disqualified for holding office as director.

9. DECLARATION BY INDEPENDENT DIRECTORS

The Company has received declarations from all the Independent Directors of the Companyconfirming that they fulfil the criteria of independence as prescribed under sub-section(6) of section 149 of the Companies Act 2013 and the Securities and Exchange Board ofIndia (Listing Obligations and Disclosure Requirements) Regulations 2015.

10. DIRECTORS RESPONSIBILITY STATEMENT

Pursuant to section 134(5) of the Companies Act 2013 the board of directors to thebest of their knowledge and ability confirm that: i. in the preparation of the annualaccounts the applicable accounting standards have been followed and there are no materialdepartures in adoption of these standards; ii. The Directors have selected such accountingpolicies and applied them consistently and made judgments and estimates that arereasonable and prudent so as to give a true and fair view of the state of affairs of theCompany at the end of the financial year and of the profit of the Company for that period;iii. The Directors have taken proper and sufficient care for the maintenance of adequateaccounting records in accordance with the provisions of the Act for safeguarding theassets of the Company and for preventing and detecting fraud and other irregularities; iv.The Directors have prepared the annual accounts on a going concern basis; v. The Directorshave laid down internal financial controls to be followed by the Company and such internalfinancial controls are adequate and operating effectively; vi. The Directors have devisedproper systems to ensure compliance with the provisions of all applicable laws and thatsuch systems were adequate and operating effectively.

11. FAMILIARIZATION OF INDEPENDENT DIRECTORS

The details of familiarization programme for Independent Directors is given in reportof corporate governance and have been disclosed on website of the Company at weblinkhttp://www.biofilgroup.net/Policies/Familiarization%20Programme%20for%20Independent%20Directors.pdf

12. MEETING OF INDEPENDENT DIRECTORS

The Independent Directors met once during the year as on 17th March 2016. The Meetingwas conducted in an informal manner without the presence of the Chairman the Whole TimeDirector the Non-Executive Non-Independent Directors and the Chief Financial Officer.

13. COMMITTEES OF THE BOARD OF DIRECTORS

The Company has various committees which have been constituted as a part of the goodcorporate governance practices and the same are in compliance with the requirements of therelevant provisions of applicable laws and statutes. Your Company has an adequatelyqualified and experienced Audit Committee with Smt. Shaila Jain (Chairperson) Mr. RomilShah and Shri Subhash Chandra Swarnkar as Members. The recommendations of the AuditCommittee were duly approved and accepted by the Board during the year under review.

The other Committees of the Board are:

(i) Nomination and Remuneration Committee (ii) Stakeholders Relationship Committee

The details with respect to the composition powers roles terms of referenceMeetings held and attendance of the Directors at such Meetings of the relevant Committeesare given in detail in the Report on Corporate Governance of the Company which forms partof this Report.

14. STATEMENT INDICATING THE MANNER IN WHICH FORMAL ANNUAL EVALUATION HAS BEEN MADE BYTHE BOARD

OF ITS OWN PERFORMANCE ITS DIRECTORS AND THAT OF ITS COMMITTEES

The Board of directors has carried out an annual evaluation of its own performanceboard committees and individual directors pursuant to the provisions of the Act and thecorporate governance requirements as prescribed by Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations 2015 ("SEBI ListingRegulations").

The performance of the board was evaluated by the board after seeking inputs from allthe directors on the basis of the criteria such as the board composition and structureeffectiveness of board processes information and functioning etc.

The performance of the committees was evaluated by the board after seeking inputs fromthe committee members on the basis of the criteria such as the composition of committeeseffectiveness of committee meetings etc. The board and the nomination and remunerationcommittee reviewed the performance of the individual directors on the basis of thecriteria such as the contribution of the individual director to the board and committeemeetings like preparedness on the issues to be discussed meaningful and constructivecontribution and inputs in meetings etc. In addition the chairman was also evaluated onthe key aspects of his role.

Performance Evaluation Criteria for Independent Directors:

The performance evaluation criteria for independent directors are determined by theNomination and Remuneration committee. An indicative list of factors that may be evaluatedinclude participation and contribution by a director commitment effective deployment ofknowledge and expertise effective management of relationship with stakeholders integrityand maintenance of confidentiality and independence of behavior and judgments

15.. PARTICULARS OF LOAN GUARANTEES AND INVESTMENTS UNDER SECTION 186

The Company has not provided any loans and guarantees pursuant to section 186 of theCompanies Act 2013.

16. PARTICULARS OF CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES

All transactions entered with Related Parties for the year under review were on arm'slength basis and in the ordinary course of business pursuant to the provisions of Section188 of the Companies Act 2013 and the Rules made there under. Further disclosure in formAOC-2 in terms of Section 134 of the Companies Act 2013 read with Companies (Accounts)Rules 2014 is set out as Annexure B.

The Details of the related party transactions as required under Accounting standard -18are set out in Note No. 9 to the financial statement forming part of this Annual Report.

All Related Party Transactions are placed before the Audit Committee and the Board forreview and approval on a quarterly basis. Omnibus approval was obtained on a quarterlybasis for transactions which are of repetitive nature. The policy on Related PartyTransactions as approved by the Board of Directors has been uploaded on the website of theCompany. The web-link of the same has been provided in the Corporate Governance Report.None of the Directors has any pecuniary relationship or transactions vis--vis theCompany.

17. CONSERVATION OF ENERGY TECHNOLOGY ABSORPTION FOREIGN EXCHANGE EARNINGS ANDOUTGO:

The particulars in respect of conservation of energy technology absorption and foreignexchange earnings and outgo as required under sub-section (3) (m) of section 134 of theCompanies Act 2013 read with Rule (8)(3) of the Companies

(Accounts) Rules 2014 are given as under :as required under sub-section (3) (m) ofsection 134 of the Companies Act 2013 read with Rule (8)(3) of the Companies (Accounts)Rules 2014 are given as under :

(A) Conservation of Energy

(i) Adequate measures have been initiated to reduce energy consumption wherevernecessary.

(ii) The company makes ongoing study to identify and implement energy saving system toreduce energy consumption and cost of production.

(iii) Maintenance of machines as per schedule.

(iv) Energy conservation is ongoing process in our company. Continues monitoringplanning development and modification for energy conservation are done at the plant.

(v) The capital investment on energy conservation equipment's: Nil

(B) Technology Absorption :

(i) The efforts made towards technology absorption: Not Applicable.

(ii) The benefits derived like product improvement cost reduction product developmentor import substitution Not Applicable.

(iii) in case of imported technology (imported during the last three years reckonedfrom the beginning of the Financial Year): Not Applicable.

(iv) Company has not incurred any expenditure on Research and Development during theyear under review. Further there was neither inflow nor outflow of foreign exchange duringthe year.

18. STATEMENT IN RESPECT OF ADEQUACY OF INTERNAL FINANCIAL CONTROL WITH REFERENCE TOTHE FINANCIAL

STATEMENTS

Your company has an effective internal control and risk mitigation system which areconstantly assessed and strengthened with new/revised standard operating procedures. Thecompany's internal control system is commensurate with its size scale and complexities ofits operations; the internal and operational audit is entrusted to M/s. Sethiya Khandelwal& Co. Chartered Accountants. The main thrust of internal audit is to test and reviewcontrols appraisal of risks and business processes besides benchmarking controls withbest practices in the industry.

The audit committee of the board of directors actively reviews the adequacy andeffectiveness of the internal control systems and suggests improvements to strengthen thesame. The company has a robust management information system which is an integral part ofthe control mechanism.

The audit committee of the board of directors statutory auditors and the businessheads are periodically apprised of the internal audit findings and corrective actionstaken. Audit plays a key role in providing assurance to the Board of director. Significantaudit observations and corrective actions taken by the management are presented to theaudit committee of the board. To maintain its objectivity and independence the internalaudit function reports to the chairman of the audit committee. Report of statutoryauditors for internal financial control system is part of Audit Report.

19. CORPORATE SOCIAL RESPONSIBILITY (CSR) POLICY

Provisions of section 135 of the Companies Act 2013 does not apply to the Companytherefore Company has not constituted Corporate Social responsibility (CSR) committee asrequired under the Act.

20. REMUNERATION POLICY / DISCLOSURE RELATING TO REMUNERATION OF DIRECTORS KEYMANAGERIAL PERSONNEL

AND PARTICULARS OF EMPLOYEES:

In accordance with Section 178 and other applicable provisions if any of the CompaniesAct 2013 read with the Rules issued there under and the SEBI (Listing Obligations andDisclosure Requirements) Regulations 2015 the Board of Directors formulated theNomination and Remuneration Policy of your Company on the recommendations of theNomination and Remuneration Committee. The Nomination and Remuneration Policy of thecompany is annexed as Annexure-C and forms an integral part of this report.

The Disclosure required under Section 197(12) of the Companies Act 2013 read with theRule 5 of the Companies (Appointment and Remuneration of Managerial Personnel) Rules 2014as amended up to date is annexed as Annexure - D and forms an integral part of thisReport None of the employee of the company is drawing more than Rs.10200000/- per annumor Rs.850000/- per month for the part of the year during the year under reviewtherefore Particulars of the employees as required under Section 197 of Companies Act2013 read with rule 5(2) & rule 5(3) of Companies (Appointment and Remuneration ofManagerial Personnel) Rules 2014 are not applicable during the year under review.

Further Company did not have any holding or subsidiary company therefore receipt of thecommission or remuneration from holding or subsidiary company of the company as providedunder section 197(14) of Companies Act 2013 is not applicable.

21. REPORTS ON CORPORATE GOVERNANCE & MANAGEMENT DISCUSSION ANALYSIS

As per Regulation 34(3) read with Schedule V of the SEBI (Listing Obligations andDisclosure Requirements) Regulations 2015 a separate section on corporate governancepractices followed by the Company together with a certificate from the PracticingChartered Accountants confirming compliance forms an integral part of this Report.

22. DISCLOSURE ON ESTABLISHMENT OF A VIGIL MECHANISM/WHISTLE BLOWER POLICY

The Company has a whistle blower policy to report genuine concerns or grievances. Thedetails of establishment of the reporting mechanism are disclosed on the website of theCompany at the weblink http://www.biofilgroup.net/Policies/Vigil%20Mechanism%20Policy%20BCPL.pdf

No Person has been denied access to the Audit Committee.

23. SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS OR TRIBUNALSIMPACTING THE

GOING CONCERN STATUS OF THE COMPANY.

There are no significant and material orders passed by the Regulators/Courts that wouldimpact the going concern status of the Company and its future operations.

24. SECRETARIAL AUDIT

Pursuant to the provisions of Section 204 of the Companies Act 2013 and Companies(Appointment and Remuneration of Managerial Personnel) Rules 2014 the company hasappointed M/s. L. N. Joshi Practicing Company Secretary to undertake as the SecretarialAuditor of the company. The Secretarial Audit report is included as ANNEXURE-E and formsan integral part of this Report. With respect to the observations of the SecretarialAuditor the Board replies hereunder:-Non Payment of Listing Fees with National StockExchange Limited: The Company has been suspended from the National Stock Exchange Limitedand matter is still pending for revocation of suspension; hence no invoice is generatedfrom NSE with respect to filling of listing fees. Although company is in compliance withthe clauses of listing agreement and duly submitted all the necessary documents as perlisting agreement/Regulations in a prescribed frame of time and further request letteralso submitted to NSE for revocation of suspension.

Trading Approval for Reissue of 5712500 Forfeited Shares: The Company has received inprincipal approval from BSE Limited subject to approval from National Stock Exchange.

25. STATUTORY AUDITORS

Pursuant to the provisions of section 139 of the Act and the rules framed thereunderM/s. S.N.Gadiya & Company Chartered Accountants (Firm Registration No.002052C) wereappointed as statutory auditors of the Company from the conclusion of the 29th AnnualGeneral Meeting (AGM) of the Company held on 23rd September 2014 till the conclusion ofthe 32nd AGM to be held in the year 2017 subject to ratification of their appointment atevery AGM.

M/s. S.N.Gadiya & Company Chartered Accountants (Firm Registration No.002052C) whoare Statutory Auditors of the Company hold office up to the forthcoming Annual GeneralMeeting and are recommended for re-appointment for the financial year 2016-17. As requiredunder the provisions of Section 139 of the Companies Act 2013 the Company has obtainedwritten confirmation from M/s. S.N.Gadiya & Company Chartered Accountants for theirappointment if made would be in conformity with the limits specified in the said Section

EXPLANATION TO AUDITOR'S REMARKS

The Auditors in their report have referred to the notes forming part of the Accountswhich are self-explanatory and does not contain any qualification reservation or adverseremark or disclaimer.

Further there was no fraud in the Company which was required to report by statutoryauditors of the Company under sub-section (12) of section 143 of Companies Act 2013.

26. COST AUDIT

The company does not falls within the provisions of Section 148 of Company's Act 2013Read with the Companies (Cost records & Audit) Rules 2014 therefore no such recordsare required to be maintained and company is not required to appoint cost auditor for thefinancial year 2016-17.

27. INTERNAL AUDITOR

The Board has appointed M/s. Sethiya Khandelwal & Company Chartered AccountantsIndore as Internal Auditor of the company and takes his suggestions and recommendationsto improve and strengthen the internal control systems. His scope of work includes reviewof operational efficiency effectiveness of systems & processes compliances andassessing the internal control strengths in all areas.

The Audit Committee reviews adequacy and effectiveness of the Company's internalcontrol environment and monitors the implementation of audit recommendations includingthose relating to strengthening of the Company's risk management policies and systems.

28. CODE OF CONDUCT

The Company has laid down a code of conduct for all Board members and senior managementand independent directors of the Company. All the Board members including independentdirectors and senior management personnel have affirmed compliance with the code ofconduct. Declaration on adherence to the code of conduct is forming part of the CorporateGovernance Report.

29. MD/CFO CERTIFICATION

As required under Regulation 17(8) of the Listing Regulations the Managing Directorand Chief Financial Officer of the Company have certified to the Board regarding theFinancial Statements for the year ended 31st March 2016.

30. CODE FOR PROHIBITION OF INSIDER TRADING PRACTICES:

Your Company has adopted the code as per SEBI (Prohibition of Insider Trading)Regulations 2015 which has been effective from 15th May 2015. The Details of the saidcode is available on website of the Company i.e www.biofilgroup.net.

31. STATEMENT INDICATING DEVELOPMENT & IMPLEMENTATION OF RISK MANAGEMENT POLICY:

The Board of Directors has adopted risk management policy for the Company whichprovides for identification assessment and control of risks which in the opinion of theBoard may threaten the existence of the Company. The Management identifies and controlsrisks through a properly defined framework in terms of the aforesaid policy.

32. MATERIAL CHANGES & COMMITMENTS IF ANY AFFECTING THE FINANCIAL POSITION OF THECOMPANY

No material changes and commitments affecting the financial position of the companyhave occurred between the end of the financial year to which the financial statementsrelate and the date of this Board's report.

33. ENVIRONMENT AND SAFETY

The Company is conscious of the importance of environmentally clean and safeoperations. The Company's policy requires conduct of operations in such a manner so as toensure safety of all concerned compliances environmental regulations and preservation ofnatural resources.

34. SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION PROHIBITION & REDRESSAL)ACT 2013

The Company has in place an Anti Sexual Harassment Policy in line with the requirementsof The Sexual Harassment of Women at Workplace (Prevention Prohibition and Redressal)Act 2013. An Internal Complaints Committee (ICC) has been set up to redress the Complaintreceived regarding sexual harassment. There was no case of sexual harassment reportedduring the year under review.

35. LISTING OF SHARES

Company's shares listed on Bombay Stock Exchange Limited & National Stock ExchangeLtd. The company has paid annual listing fee for financial year 2016-17 to Bombay StockExchange. Further company had reissued of 5712500 forfeited equity shares on 31.03.2011.The Company has received "in principal approval letter" from Bombay StockExchange Ltd. Subject to listing at National Stock Exchange Ltd.

Further the National Stock Exchange Ltd has suspended the trading in shares and matteris still pending for revocation of suspension and listing fee will be paid at the time ofrevocation of suspension.

36. BUSINESS RESPONSIBILITY REPORT:

The Business Responsibility Reporting as required by Regulation 34(2) of the SEBI(Listing Obligations & Disclosure Requirements) Regulations 2015 is not applicableto your Company for the financial year ending March 31 2016.

37. DEPOSITORY SYSTEM

Your Company's shares are tradable compulsorily in electronic form and your Company hasconnectivity with both the Depositaries i.e. National Securities Depository Limited (NSDL)and Central Depository Service (India) Limited (CDSL). In view of the numerous advantageoffered by the Depository System members are requested to avail of the facility ofDematerialization of the Company's shares on either of the Depositories mentioned asaforesaid. The Company has paid the annual custodian fee to both the depositories

38. INDUSTRIAL RELATIONS:

Company's Industrial relations continued to be healthy cordial and harmonious duringthe period under review.

39. AMENDMENT TO THE ARTICLES OF ASSOCIATION OF THE COMPANY

At the 30th Annual General Meeting held on 24th September 2015 based on the approvalof the Members the Company adopted new Articles of Association which had been streamlinedand aligned with the Companies Act 2013 and Rules made there under.

40. ACKNOWLEDGMENT

The Board of Directors wish to place on record its appreciation for the extendedco-operation and assistance rendered to the Company and acknowledge with gratitude thecontinued support and cooperation extended by the investors stakeholders Banks and otherregulatory authorities.

On behalf of the Board of
Biofil Chemicals & Pharmaceuticals Ltd.
Ramesh S. Shah Romil Shah
Place : Indore Managing Director Director
Date : 10th August 2016 (DIN: 00028819) (DIN: 00326110)